Casdin Partners FO1-MSV, Director of Standard Biotools LAB, has filed 21 purchases and 0 sales on the open market. The latest trade was on 24/06/18.

CF

CF

Casdin Partners FO1-MSV

Director

Company

Standard Biotools LAB

First filing

23/05/19

Trades

30 trades

Buys / sales

21 / 0

12-month net buying

No record

Last trade

24/06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
GeneDx HoldingsWGS	Open-market buy	24/06/03–24/06/04	24/06/05	130,000 sh2 trades	$21.21avg.	$2,757,600	+4.4%
GeneDx HoldingsWGS	Open-market buy	24/05/29	24/05/31	40,000 sh	$21.07	$842,800	+1.4%
GeneDx HoldingsWGS	Open-market buy	24/05/23–24/05/28	24/05/28	170,000 sh3 trades	$20.15avg.	$3,425,393.96	+6.2%
Standard BiotoolsLAB	Open-market buy	24/05/23	24/05/28	100,000 sh	$2.60	$260,000	+0.2%
Standard BiotoolsLAB	Open-market buy	24/05/20–24/05/22	24/05/22	600,000 sh3 trades	$2.57avg.	$1,541,000	+1.3%
Standard BiotoolsLAB	Open-market buy	24/05/15–24/05/17	24/05/17	1,352,072 sh3 trades	$2.56avg.	$3,456,304.32	+3.1%
GeneDx HoldingsWGS	Open-market buy	24/05/13	24/05/15	50,000 sh	$23.31	$1,165,500	+1.8%
Standard BiotoolsLAB	Open-market buy	24/03/04–24/03/05	24/03/06	251,403 sh2 trades	$2.57avg.	$646,175.86	+2.2%
GeneDx HoldingsWGS	Open-market buy	24/03/04–24/03/05	24/03/06	40,900 sh2 trades	$8.74avg.	$357,547	+1.5%
Standard BiotoolsLAB	Open-market buy	23/05/17–23/05/19	23/05/19	1,200,000 sh3 trades	$2.19avg.	$2,628,500	No record